Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maclura pomifera pollen is an allergenic extract derived from the pollen of the Osage orange tree (*Maclura pomifera*). It is used as a diagnostic tool in allergy testing, specifically for skin prick or intradermal testing, to identify patients with allergic sensitization to Osage orange pollen. The extract contains a complex mixture of proteins that, when introduced to a sensitized individual, cross-link specific IgE antibodies on the surface of mast cells and basophils. This interaction triggers the release of inflammatory mediators, resulting in a localized wheal-and-flare reaction that confirms sensitization. The product was originally approved in the United States in 1967 as a biologic under BLA 101376.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maclura pomifera pollen.